Health News

New Study Claims Heavy Drinking During Middle Life Can Lead to Stroke

It is already known that alcohol can have bad effects on our health, but as per the new study at the International Clinical Research Center of St. Anne’s University Hospital in Czech Republic consuming more than two alcoholic drinks a day during middle life can increase your risk of stroke by more than a third. The team published their new findings in Stroke – a journal of the American Heart Association. The study also claims that they have over 700,000 cases of stroke every year in the United States and the condition is responsible for more than 130,000 deaths each year.

Read more

Reduce Your Obesity and Type 2 Diabetes Using Your Brown Fat

Obesity is certainly among the top health concerns, along with diabetes, but as per a new study brown fat can protect your body from obesity and diabetes naturally. The new research study claims that it focuses specifically on brown fat that is present in small quantities in adults. The research report claims that brown fat is mostly present in newborn babies as they are more prone to heat loss and since they are unable to shiver and brown fat helps them to stay warm. However, as we grow the body requires less amount of brown fat and therefore it is replaced by white fat which can lead to many more health concerns.

Read more

EnteroMedic’s Maestro Rechargeable System Approved by FDA

Obesity is a major health concern in the United States and now FDA has gone ahead and approved a new weight loss device that can be surgically implanted to treat obesity. The Maestro Rechargeable System is the first device since 2007 that has got an approval from FDA and can treat patients above 18 years of age. The device is designed to help patients that find it difficult to lose weight. As per FDA the device is fit for patients that have a body mass index of 35-45 with at least one other obesity-related condition like Type 2 diabetes.

Read more

Scientists and Medical Experts Begin Ebola Drug Trials in Liberia

Ebola has been in the news for quite some time now and medical experts around the world are already in search for the best solution to this disease. A new trial of the potential drug has now begun at the Medecins Sans Frontieres Centre in Liberia. Medical experts are now working on Brincidofovir, the antiviral that is being tested on Ebola patients on a voluntary basis. According to the experts, drugs, blood samples and vaccines are being tested against the disease to ensure that an effective solution can be found to combat this deadly disease. The study will also focus on another similar drug called Favipiravir as it has showed some potential results against the disease.

Read more

The most exceptional benefits from the Medical Technology investment today

Have you geared up to invest your hard-earned money in the most profitable investment plan? It is time to choose Medical Technology investment options to invest your money profitably. Residents of many countries have started to invest in the medical technology since they understand the ever increasing importance of this technology.  Do you wish to know leading reasons for why well-experienced investors prefer medical technology? Rapid technology advancements in this medical technology give the absolute support to augment the market requirements. A noticeable improvement in the medical technology requirements of the healthcare systems makes this kind of investment plan renowned.

Read more

First International Review Claims E-Cigs Can Help Reverse Smoking Habits

Can e-cigarettes really help you to quit smoking? This has been a major question for many smokers that are willing to get rid of their smoking habit and also for health agencies that would like to find an alternative to smoking. As per the first international review, e-cigarettes can help smokers to quit smoking to some extent, but it has also created a new generation of addicts. The first Cochrane review that involves authors from the UK and New Zealand mentions that they considered two randomized trials with data from 662 smokers.

Read more